These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2732847)

  • 1. Quantitative and mechanistic measurements of container/closure integrity. Bubble, liquid, and microbial leakage tests.
    Morton DK; Lordi NG; Troutman LH; Ambrosio TJ
    J Parenter Sci Technol; 1989; 43(3):104-8. PubMed ID: 2732847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative and mechanistic measurements of parenteral vial container/closure integrity. Leakage quantitation.
    Morton DK; Lordi NG; Ambrosio TJ
    J Parenter Sci Technol; 1989; 43(2):88-97. PubMed ID: 2709241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Method Development for Container Closure Integrity Evaluation via Headspace Gas Ingress by Using Frequency Modulation Spectroscopy.
    Victor KG; Levac L; Timmins M; Veale J
    PDA J Pharm Sci Technol; 2017; 71(6):429-453. PubMed ID: 28733333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying the Vial Capping Process: Residual Seal Force and Container Closure Integrity.
    Ovadia R; Streubel A; Webb-Vargas Y; Ulland L; Luemkemann J; Rauch K; Eder J; Lam P; Tegoulia V; Maa YF
    PDA J Pharm Sci Technol; 2019; 73(1):2-15. PubMed ID: 29954924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Balancing Container Closure Integrity and Aesthetics for a Robust Aseptic or Sterile Vial Packaging System.
    Oni Y; Song X; Schrader M; Kulshrestha A; Franck J; Asselta R; Flores-Crespo C; Mantri RV
    PDA J Pharm Sci Technol; 2019; 73(6):572-587. PubMed ID: 31101708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Container Closure System Integrity for Frozen Storage Drug Products.
    Nieto A; Roehl H; Brown H; Nikoloff J; Adler M; Mahler HC
    PDA J Pharm Sci Technol; 2016; 70(2):120-33. PubMed ID: 26797976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrity testing of vial closure systems used for parenteral products.
    Frieben WR; Folck RJ; Devisser A
    J Parenter Sci Technol; 1982; 36(3):112-6. PubMed ID: 7097453
    [No Abstract]   [Full Text] [Related]  

  • 8. Artificial Leaks in Container Closure Integrity Testing: Nonlinear Finite Element Simulation of Aperture Size Originated by a Copper Wire Sandwiched between the Stopper and the Glass Vial.
    Nieto A; Roehl H; Brown H; Adler M; Chalus P; Mahler HC
    PDA J Pharm Sci Technol; 2016; 70(4):313-24. PubMed ID: 27020649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Container Closure Integrity Testing-Practical Aspects and Approaches in the Pharmaceutical Industry.
    Brown H; Mahler HC; Mellman J; Nieto A; Wagner D; Schaar M; Mathaes R; Kossinna J; Schmitting F; Dreher S; Roehl H; Hemminger M; Wuchner K
    PDA J Pharm Sci Technol; 2017; 71(2):147-162. PubMed ID: 27789803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Holistic Considerations in Optimizing a Sterile Product Package to Ensure Container Closure Integrity.
    Degrazio FL
    PDA J Pharm Sci Technol; 2018; 72(1):15-34. PubMed ID: 29030527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical container/closure integrity. II: The relationship between microbial ingress and helium leak rates in rubber-stoppered glass vials.
    Kirsch LE; Nguyen L; Moeckly CS; Gerth R
    PDA J Pharm Sci Technol; 1997; 51(5):195-202. PubMed ID: 9357305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Container Closure Integrity Testing-Method Development for Freeze-Dried Products Using Laser-Based Headspace Oxygen Analysis.
    Hede JO; Fosbøl PL; Berg SW; Dahl S
    PDA J Pharm Sci Technol; 2019; 73(2):170-180. PubMed ID: 30361284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing Physical Container Closure Integrity Test Methods and Artificial Leak Methodologies.
    Peláez SS; Mahler HC; Herdlitschka C; Wertli T; Kahl M; Koulov A; Matter A; Singh SK; Widmer M; Germershaus O; Mathaes R
    PDA J Pharm Sci Technol; 2019; 73(3):220-234. PubMed ID: 30651337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simulated Leaching (Migration) Study for a Model Container-Closure System Applicable to Parenteral and Ophthalmic Drug Products.
    Jenke D; Egert T; Hendricker A; Castner J; Feinberg T; Houston C; Hunt DG; Lynch M; Nicholas K; Norwood DL; Paskiet D; Ruberto M; Smith EJ; Holcomb F; Markovic I
    PDA J Pharm Sci Technol; 2017; 71(2):68-87. PubMed ID: 27974627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-destructive vacuum decay method for pre-filled syringe closure integrity testing compared with dye ingress testing and high-voltage leak detection.
    Simonetti A; Amari F
    PDA J Pharm Sci Technol; 2015; 69(1):108-22. PubMed ID: 25691719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leak testing in parenteral packaging: establishment of direct correlation between helium leak rate measurements and microbial ingress for two different leak types.
    Morrical BD; Goverde M; Grausse J; Gerwig T; Vorgrimler L; Morgen R; Büttiker JP
    PDA J Pharm Sci Technol; 2007; 61(4):226-36. PubMed ID: 17933206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality-control plan for intravenous admixture programs. I: Visual inspection of solutions and environmental testing.
    Morris BG; Avis KE
    Am J Hosp Pharm; 1980 Feb; 37(2):189-95. PubMed ID: 7361790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a dye ingress method to assess container-closure integrity: correlation to microbial ingress.
    Burrell LS; Carver MW; DeMuth GE; Lambert WJ
    PDA J Pharm Sci Technol; 2000; 54(6):449-55. PubMed ID: 11107837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of Different Container Closure Systems and Capping Process Parameters on Product Quality and Container Closure Integrity (CCI) in GMP Drug Product Manufacturing.
    Mathaes R; Mahler HC; Roggo Y; Huwyler J; Eder J; Fritsch K; Posset T; Mohl S; Streubel A
    PDA J Pharm Sci Technol; 2016; 70(2):109-19. PubMed ID: 26797971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Draft guidance for industry; container and closure integrity testing in lieu of sterility testing as a component of the stability protocol for sterile products; availability--FDA. Notice.
    Fed Regist; 1998 Jan; 63(18):4272-3. PubMed ID: 10177326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.